These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 369959)

  • 21. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease].
    Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selected bacterial antibodies in Crohn's disease and ulcerative colitis.
    Auer IO; Röder A; Wensinck F; van de Merwe JP; Schmidt H
    Scand J Gastroenterol; 1983 Mar; 18(2):217-23. PubMed ID: 6673050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between site of disease and familial occurrence in Crohn's disease.
    Cottone M; Brignola C; Rosselli M; Oliva L; Belloli C; Cipolla C; Orlando A; De Simone G; Aiala MR; Di Mitri R; Gatto G; Buccellato A
    Dig Dis Sci; 1997 Jan; 42(1):129-32. PubMed ID: 9009127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Colicinogens in nonspecific intestinal inflammation. I. Colicinotypes in patients with ulcerous colitis, Crohn's disease and in healthy individuals].
    Bures J; Horák V; Buresová E; Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1983 Mar; 37(2):81-6. PubMed ID: 6342822
    [No Abstract]   [Full Text] [Related]  

  • 26. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics and IBD.
    De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman-Wauters G
    Acta Gastroenterol Belg; 2013 Mar; 76(1):15-9. PubMed ID: 23650777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial L-form isolation from inflammatory bowel disease patients.
    Belsheim MR; Darwish RZ; Watson WC; Schieven B
    Gastroenterology; 1983 Aug; 85(2):364-9. PubMed ID: 6134652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative assessment of intestinal microflora in Crohn's disease and non-specific ulcerative colitis].
    Marko OP; Levitan MKh; Turovtseva VV; Dzhimbeev VL
    Klin Med (Mosk); 1977; 55(1):95-100. PubMed ID: 839703
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudomonas-like group Va bacteria in Crohn's disease.
    Parent K; Mitchell P
    Gastroenterology; 1978 Oct; 75(4):765. PubMed ID: 710845
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
    Bendixen G
    Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ulcerative colitis and Crohn's disease of the colon. Is there a macroscopic difference?
    Palnaes Hansen C; Hegnhøj J; Møller A; Brauer C; Hage E; Jarnum S
    Ann Chir Gynaecol; 1990; 79(2):78-81. PubMed ID: 2386361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
    Wehkamp J; Schmid M; Fellermann K; Stange EF
    J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
    Duchmann R; Lochs H; Kruis W
    MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota in pediatric inflammatory bowel disease.
    Schwiertz A; Jacobi M; Frick JS; Richter M; Rusch K; Köhler H
    J Pediatr; 2010 Aug; 157(2):240-244.e1. PubMed ID: 20400104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease.
    Schippa S; Conte MP; Borrelli O; Iebba V; Aleandri M; Seganti L; Longhi C; Chiarini F; Osborn J; Cucchiara S
    Inflamm Bowel Dis; 2009 May; 15(5):661-72. PubMed ID: 19067417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease.
    Zitomersky NL; Atkinson BJ; Franklin SW; Mitchell PD; Snapper SB; Comstock LE; Bousvaros A
    PLoS One; 2013; 8(6):e63686. PubMed ID: 23776434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease.
    Keita AV; Salim SY; Jiang T; Yang PC; Franzén L; Söderkvist P; Magnusson KE; Söderholm JD
    J Pathol; 2008 Jun; 215(2):135-44. PubMed ID: 18348161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.